Nurix Therapeutics Inc
NASDAQ:NRIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
Evergreen Marine Corp Taiwan Ltd
TWSE:2603
|
TW |
|
J&T Global Express Ltd
F:J92
|
CN |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
ArcBest Corp
NASDAQ:ARCB
|
US |
|
Cooper-Standard Holdings Inc
NYSE:CPS
|
US |
|
Medtronic PLC
NYSE:MDT
|
IE |
|
DIP Corp
TSE:2379
|
JP |
|
Brinks Co
NYSE:BCO
|
US |
|
Chemed Corp
NYSE:CHE
|
US |
|
Cigna Corp
NYSE:CI
|
US |
|
Pernod Ricard SA
PAR:RI
|
FR |
Wall St Price Targets
NRIX Price Targets Summary
Nurix Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
NRIX is 31.01 USD with a low forecast of 23.23 USD and a high forecast of 43.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NRIX's stock price target?
Price Target
31.01
USD
According to Wall Street analysts, the average 1-year price target for
NRIX is 31.01 USD with a low forecast of 23.23 USD and a high forecast of 43.05 USD.
What is the Revenue forecast for Nurix Therapeutics Inc?
Projected CAGR
45%
Over the last 6 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is 45%.